558 related articles for article (PubMed ID: 20133390)
21. The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6.
Snider NT; Sikora MJ; Sridar C; Feuerstein TJ; Rae JM; Hollenberg PF
J Pharmacol Exp Ther; 2008 Nov; 327(2):538-45. PubMed ID: 18698000
[TBL] [Abstract][Full Text] [Related]
22. From cannabis to cannabinergics: new therapeutic opportunities.
Goutopoulos A; Makriyannis A
Pharmacol Ther; 2002 Aug; 95(2):103-17. PubMed ID: 12182958
[TBL] [Abstract][Full Text] [Related]
23. Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
Clapper JR; Moreno-Sanz G; Russo R; Guijarro A; Vacondio F; Duranti A; Tontini A; Sanchini S; Sciolino NR; Spradley JM; Hohmann AG; Calignano A; Mor M; Tarzia G; Piomelli D
Nat Neurosci; 2010 Oct; 13(10):1265-70. PubMed ID: 20852626
[TBL] [Abstract][Full Text] [Related]
24. Natural and synthetic endocannabinoids and their structure-activity relationships.
Palmer SL; Khanolkar AD; Makriyannis A
Curr Pharm Des; 2000 Sep; 6(13):1381-97. PubMed ID: 10903399
[TBL] [Abstract][Full Text] [Related]
25. Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms.
Maione S; Morera E; Marabese I; Ligresti A; Luongo L; Ortar G; Di Marzo V
Br J Pharmacol; 2008 Nov; 155(5):775-82. PubMed ID: 18660824
[TBL] [Abstract][Full Text] [Related]
26. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.
Mechoulam R
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):93-9. PubMed ID: 12052029
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid amide hydrolase inhibitors--progress and potential.
Khanna IK; Alexander CW
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
[TBL] [Abstract][Full Text] [Related]
28. The endocannabinoid system and pain.
Guindon J; Hohmann AG
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
[TBL] [Abstract][Full Text] [Related]
29. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
30. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
[TBL] [Abstract][Full Text] [Related]
31. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility.
Maccarrone M; Valensise H; Bari M; Lazzarin N; Romanini C; Finazzi-Agrò A
J Immunol; 2001 Jun; 166(12):7183-9. PubMed ID: 11390466
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
Hwang J; Adamson C; Butler D; Janero DR; Makriyannis A; Bahr BA
Life Sci; 2010 Apr; 86(15-16):615-23. PubMed ID: 19527737
[TBL] [Abstract][Full Text] [Related]
33. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
[TBL] [Abstract][Full Text] [Related]
34. Identification of intracellular carriers for the endocannabinoid anandamide.
Kaczocha M; Glaser ST; Deutsch DG
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6375-80. PubMed ID: 19307565
[TBL] [Abstract][Full Text] [Related]
35. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
Long JZ; Nomura DK; Vann RE; Walentiny DM; Booker L; Jin X; Burston JJ; Sim-Selley LJ; Lichtman AH; Wiley JL; Cravatt BF
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20270-5. PubMed ID: 19918051
[TBL] [Abstract][Full Text] [Related]
36. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.
Hillard CJ
Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):3-18. PubMed ID: 10785538
[TBL] [Abstract][Full Text] [Related]
37. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
[TBL] [Abstract][Full Text] [Related]
38. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
[TBL] [Abstract][Full Text] [Related]
39. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
40. Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.
Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F
Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):263-272. PubMed ID: 31522241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]